Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies

dc.contributor.authorGuasp, Mar
dc.contributor.authorLanda Medrano, Jon
dc.contributor.authorMartínez Hernández, Eugenia
dc.contributor.authorSabater Baudet, Lidia
dc.contributor.authorIizuka, Takahiro
dc.contributor.authorSimabukuro, Mateus
dc.contributor.authorNakamura, Masataka
dc.contributor.authorKinoshita, Makoto
dc.contributor.authorKaida, Kenichi
dc.contributor.authorBruna, Jordi
dc.contributor.authorKapetanovic, Solange
dc.contributor.authorSánchez, Pedro
dc.contributor.authorRuiz García, Raquel
dc.contributor.authorNaranjo, Laura
dc.contributor.authorPlanagumà, Jesús
dc.contributor.authorMuñoz Lopetegi, Amaia
dc.contributor.authorBataller, Luis
dc.contributor.authorSaiz Hinarejos, Albert
dc.contributor.authorDalmau Obrador, Josep
dc.contributor.authorGraus Ribas, Francesc
dc.contributor.authorKurihara, Masanori
dc.date.accessioned2022-01-27T16:07:48Z
dc.date.available2022-01-27T16:07:48Z
dc.date.issued2021-07-23
dc.date.updated2022-01-27T10:17:22Z
dc.description.abstractTo report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma.A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques.Patients' median age was 52 years (range: 23-88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABAAR) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti-collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABAAR, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABAAR encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis).AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABAAR encephalitis was the most frequent AE and occurred more frequently in Japanese patients.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec720212
dc.identifier.idimarina9274278
dc.identifier.issn2332-7812
dc.identifier.pmid34301822
dc.identifier.urihttps://hdl.handle.net/2445/182720
dc.language.isoeng
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1212/nxi.0000000000001053
dc.relation.ispartofNeurology-Neuroimmunology & Neuroinflammation, 2021, vol. 8, num. 5, p. e1053
dc.relation.urihttps://doi.org/10.1212/nxi.0000000000001053
dc.rightscc by-nc-nd (c) Guasp, Mar et al., 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationEncefalitis
dc.subject.classificationEstudi de casos
dc.subject.classificationImmunologia
dc.subject.otherEncephalitis
dc.subject.otherCase studies
dc.subject.otherImmunology
dc.titleThymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
12474_9274278_thymomae1053.full.pdf
Mida:
493.55 KB
Format:
Adobe Portable Document Format